A new experimental drug called CS18 may help break through cancer drug resistance by disabling several of the defenses tumors ...
Lung cancer remains one of the most formidable challenges in modern oncology, and a new study from researchers at the ...
Morning Overview on MSN
Lab compound reverses lung cancer’s resistance to a key cancer drug
CS18, a lab-made compound developed at Baylor College of Medicine, restored a lung cancer drug’s effectiveness in cells that ...
Non-small-cell lung cancer (NSCLC) is the most common type of cancer affecting the lungs. The diverse types of NSCLC are characterized by cancer cells that grow and spread in different ways. The three ...
Lung cancer remains the deadliest malignancy on the planet, and a sweeping new analysis of twenty years of scientific ...
About 25% of lung adenocarcinomas have mutations of the gene KRAS, which drives uncontrolled cell growth. In recent years, the FDA has approved two KRAS inhibitors to treat patients with KRAS ...
What Does Resistance to Targeted Therapy Mean? Targeted therapies for cancer are medicines designed to precisely target the protein that’s making your cancer grow. In the case of epidermal growth ...
Vaccines.gov's ZIP code search is not working as flu season starts. Here is how to find flu, COVID, and RSV shots at pharmacies and health centers. Sandoz will pay $400 million to settle state claims ...
The highly anticipated study found that ivonescimab reduced the risk of death by 34% compared with another drug Summit Therapeutics and Akeso shared more data for their experimental lung-cancer drug ...
When John Ebers was diagnosed with Stage 3 colorectal cancer, he was not given the option of genetic testing, which could ...
Researchers from The University of Texas MD Anderson Cancer Center have discovered that some cancer cells express the YAP1 protein only after treatment with chemotherapy, allowing them to survive by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results